Medical device firm TransEnterix has signed an agreement to sell the SurgiBot System and its assets to Great Belief International (GBIL).

SurgiBot System is a single-port laparoscopic surgical platform that has been robotically enhanced.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

After completion of the deal, GBIL will manufacture the system in China and obtain clearance from the Chinese Food and Drug Administration (CFDA).

The firm also plans to form a nationwide distribution agreement with China National Scientific and Instruments and Materials (CSIMC) to enhance commercial potential and optimise post-sale services for national hospitals.

TransEnterix is set to receive around $29m and will retain the option to distribute or co-distribute the system outside of China.

“We believe this relationship provides us with a significant opportunity to expand our product offerings of robotic solutions for hospitals and patients around the world.”

From the total deal, $7.5m will be paid by the end of this year, another $7.5m in March next year and the remaining $14m on receiving Chinese regulatory approval or within five years, whichever is earlier.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

TransEnterix president and CEO Todd Pope said: “The relationship announced today with GBIL will allow us to advance the SurgiBot System towards global commercialisation, while significantly reducing our required investment and simultaneously leveraging in-country manufacturing in the world’s most populous country.

“We believe this relationship provides us with a significant opportunity to expand our product offerings of robotic solutions for hospitals and patients around the world.”

In October, TransEnterix obtained the FDA 510(k) clearance for its Senhance Surgical Robotic System designed to allow surgeons to precisely direct small surgical instruments.

The robotic surgery platform includes haptic feedback for security and eye-sensing camera for control.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact